YRDC_HUMAN - dbPTM
YRDC_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID YRDC_HUMAN
UniProt AC Q86U90
Protein Name YrdC domain-containing protein, mitochondrial
Gene Name YRDC
Organism Homo sapiens (Human).
Sequence Length 279
Subcellular Localization Mitochondrion . Membrane
Peripheral membrane protein. Predominantly localized in the plasma membrane..
Protein Description May regulate the activity of some transporters..
Protein Sequence MSPARRCRGMRAAVAASVGLSEGPAGSRSGRLFRPPSPAPAAPGARLLRLPGSGAVQAASPERAGWTEALRAAVAELRAGAVVAVPTDTLYGLACAASCSAALRAVYRLKGRSEAKPLAVCLGRVADVYRYCRVRVPEGLLKDLLPGPVTLVMERSEELNKDLNPFTPLVGIRIPDHAFMQDLAQMFEGPLALTSANLSSQASSLNVEEFQDLWPQLSLVIDGGQIGDGQSPECRLGSTVVDLSVPGKFGIIRPGCALESTTAILQQKYGLLPSHASYL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MSPARRCRG
------CCHHHHHHH
27.5424719451
17PhosphorylationMRAAVAASVGLSEGP
HHHHHHHHHCCCCCC
13.6424641631
21O-linked_GlycosylationVAASVGLSEGPAGSR
HHHHHCCCCCCCCCC
34.2823301498
21PhosphorylationVAASVGLSEGPAGSR
HHHHHCCCCCCCCCC
34.2828555341
27PhosphorylationLSEGPAGSRSGRLFR
CCCCCCCCCCCCCCC
25.9428555341
29PhosphorylationEGPAGSRSGRLFRPP
CCCCCCCCCCCCCCC
29.9326270265
34MethylationSRSGRLFRPPSPAPA
CCCCCCCCCCCCCCC
46.9754560703
37PhosphorylationGRLFRPPSPAPAAPG
CCCCCCCCCCCCCCC
36.0529255136
49MethylationAPGARLLRLPGSGAV
CCCCEEEECCCCCCC
43.35115920229
53PhosphorylationRLLRLPGSGAVQAAS
EEEECCCCCCCCCCC
22.9529396449
60PhosphorylationSGAVQAASPERAGWT
CCCCCCCCHHHCCHH
30.2429255136
67PhosphorylationSPERAGWTEALRAAV
CHHHCCHHHHHHHHH
15.5126074081
87PhosphorylationGAVVAVPTDTLYGLA
CCEEEECCCHHHHHH
34.7129978859
89PhosphorylationVVAVPTDTLYGLACA
EEEECCCHHHHHHHH
25.1029978859
91PhosphorylationAVPTDTLYGLACAAS
EECCCHHHHHHHHHH
16.5229978859
98PhosphorylationYGLACAASCSAALRA
HHHHHHHHHHHHHHH
7.0629978859
100PhosphorylationLACAASCSAALRAVY
HHHHHHHHHHHHHHH
17.6829978859
116UbiquitinationLKGRSEAKPLAVCLG
HCCCCCCCCHHHHHH
36.19-
116AcetylationLKGRSEAKPLAVCLG
HCCCCCCCCHHHHHH
36.1927452117
150O-linked_GlycosylationDLLPGPVTLVMERSE
HHCCCCEEEEEECHH
19.4423301498
161UbiquitinationERSEELNKDLNPFTP
ECHHHHCCCCCCCCC
75.9927667366
167PhosphorylationNKDLNPFTPLVGIRI
CCCCCCCCCCCCCCC
19.5727050516
238PhosphorylationSPECRLGSTVVDLSV
CCCCCCCCEEEEECC
23.7121406692
239PhosphorylationPECRLGSTVVDLSVP
CCCCCCCEEEEECCC
23.8121406692
244PhosphorylationGSTVVDLSVPGKFGI
CCEEEEECCCCCCCC
23.0821406692
277PhosphorylationGLLPSHASYL-----
CCCCCHHHCC-----
22.8828796482
278PhosphorylationLLPSHASYL------
CCCCHHHCC------
19.7428796482

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of YRDC_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of YRDC_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of YRDC_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of YRDC_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of YRDC_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37 AND SER-60, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, AND MASSSPECTROMETRY.

TOP